Skip to content
The Bio Report cover art

All episodes

The Bio Report, 641 episodes. Page 4 of 7.

#
Title
301

Sloan-Kettering Spin-Out Harnesses AI to Diagnose Cancer

302

Bringing Innovation to Cell and Gene Therapy Manufacturing

303

Tapping Psychedelics for their Anti-Inflammatory Powers

304

Advancing Cell Therapies Beyond Cancer

305

How the Pandemic Transformed a Small Diagnostics Company

306

Eliminating Security, Privacy, and Regulatory Burdens with Synthetic Data

307

Using Computational Discovery to Build Better Immunotherapies

308

The Year in Biotech and What’s Ahead in 2021

309

Bringing Precision Cancer Care to Dogs

310

As COVID-19 Vaccines Ship, One Company Brings Innovation to the Vials

311

Advancing an Antibody to Prevent and Treat Cytokine Storms in COVID-19

312

Using AI Created Digital Twins to Accelerate Clinical Trials

313

Modulating RNA to Quell Disease

314

A Quest to Extend Life through Early Disease Detection

315

Modulating a Gatekeeper of Cellular Metabolism to Treat a Range of Diseases

316

Finding the Best Cell for the Job

317

Transforming Clinical Trials with Digital Technology

318

Designing Immunotherapies that Can Overcome Recurrence and Resistance

319

Extending Precision Medicine Beyond Cancer

320

Growing Biologics

321

An Experimental COVID-19 Vaccine Begins Human Clinical Trials

322

Speeding the Delivery of CAR-T Therapies While Cutting the Cost

323

Transforming Infused Biologics into Injectables

324

A Novel Approach to NASH That May Have Benefits for COVID 19 As Well

325

Will a Focus on Protein Dysregulation Help Prothena Break from the Fold

326

After FDA Set Back, AI Driven Drug Company Advances with New CEO

327

A Gamified Therapy System Helps People with Brain Injury Recover

328

Genentech Drug Offers Oral, at-Home Option for SMA Patients

329

Enabling Precision Medicine through Proteomics

330

Battling Drug-Resistant Fungal Infections

331

Making Colorectal Cancer Screening Less of a Pain in the Ass

332

Targeting Diseases of Aging at a Cellular Level

333

Cracking the Immune System with AI

334

Using AI to Improve Drug Companies’ Regulatory Performance

335

Delivering Biologics Orally

336

Turning Proteins into Device Coatings that Provide Therapeutic Benefits

337

Testing if an Approved Antiviral May Prevent COVID-19 Outbreaks

338

Using AI to Crack COVID-19

339

Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19

340

Modernizing Phage Therapy to Kill Multidrug-Resistant Bacteria

341

A Rare Disease Drug Hunter Turns His Attention to COVID-19

342

What It Will Take to Move Beyond the Pandemic

343

Reading, Writing, and Erasing the Way to Epigenetic Cancer Therapies

344

Better Immunotherapies Through Chemistry

345

Bringing the Trial to the Patient

346

Controlling the Activity of Cell and Gene Therapies with Precision

347

Why Soon-Shiong Thinks His Triangle Offense for Cancer Can Be Applied to COVID-19

348

COVID-19, Vaccine Development, and Global Health Lessons from Ebola

349

Improving Cancer Outcomes with Early Diagnosis

350

Making A Social Contract That’s Enforceable

351

Treating Alzheimer’s Disease as an Autoimmune Condition

352

Fishing for New Drugs

353

Thoughts on the State of the Antimicrobial Arsenal

354

A MedTech Company That Thinks Like a Biopharma

355

Tapping the Potential of Psychedelics to Treat Psychiatric Conditions

356

Quantifying Neurodegeneration with Precision

357

Orasis Developing Eye Drops as Alternative to Reading Glasses

358

Reversing Disease Signals

359

Turning Cold Tumors Hot

360

Stabilizing Neuronal Connections to Treat Cognitive Impairment in Alzheimer’s

361

Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein

362

An Effort to Eradicate Preventable Blindness

363

Seeking Success Where Others Have Failed

364

A New Antibiotic with a Unique Mechanism of Action Hits the Market

365

Improving Health with Better Data

366

An Effort to Bioprint a Transplantable Human Heart

367

How Doctors Are Cracking Difficult Cases with a Social Network

368

Cala Health Hopes to Win Over Payers and Providers with Its Bioelectric Medicine

369

Shaping the Emerging Bioeconomy

370

A Belief that Early Interventions Will Be the Key to Treating Alzheimer’s Disease

371

Transforming the Study of Microbes with High-Throughput Technology

372

Using RNA Diagnostics to Predict Patient Response to Immunotherapies

373

How a Clever Business Model May Accelerate the Use of Companion Diagnostics

374

Building Cell Therapies with Switches to Modulate Their Activity

375

Using Synthetic Biology to Build Intelligence into Cell and Gene Therapies

376

A Therapeutic Approach Built on Protein Degradation

377

Harnessing AI to Improve Sales and Marketing Decision-Making

378

A Doctor’s Quest to Cure His Own Rare Disease

379

Athersys Advances Off-the-Shelf Stem Cell Therapy for Stroke

380

Enlisting the Innate Immune System to Fight Cancer and other Diseases

381

Using AI to Improve Clinical Development

382

Addressing the Challenge of Making Antibody-Drug Conjugates

383

Targeting Regulators of Genes to Treat Cancer

384

Harnessing the Immune System to Diagnose and Treat Cancer

385

Using Synthetic Biology to Produce Cannabinoids

386

EpicentRx Hopes Rocket-Fuel-Derived Drug Will Propel It

387

Using Fruit Flies to Personalize Cancer Therapies

388

Bridging the Gap Between Data and Knowledge with AI

389

How Virtual Reality May Change the Way Researchers Discover and Develop Drugs

390

Addressing the Challenges of Drug Development with a New Market

391

Addressing the Challenge of Producing Stem Cell Therapies with Consistency at Scale

392

Ensuring a Placebo Response Doesn’t Derail a Clinical Trial

393

Using AI to Find New Uses for Validated Drugs

394

Using Digital Health to Change Our Understanding of What Drives Disease

395

Cidara Advances Antiviral Conjugate to Treat and Prevent Flu

396

Building a Drug Empire on Undervalued Assets

397

Bringing Precision Medicine to Autoimmune Disease

398

Fighting Drug-Resistant Fungal Infections

399

Accelerating Early-Stage Biotechs

400

Agenus Advances Broad Immuno-Oncology Pipeline